Autopsy report · NCT00506701

Effect of Tadalafil in Chronic Obstructive Lung Disease Patients Suffering From Secondary Pulmonary Hypertension

“due to lack of finance”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Herlev Hospital

Sponsor type

University, hospital or other

Conditions

Chronic Obstructive Lung Disease

Interventions

Tadalafil

Participants

0

Sites

1

Countries

Denmark

Trials that died the same way

• To Study and Compare the Clinical Course and Development of Organ Failure in Severe Acute Hepatitis Without Ascites, Non-cirrhotic and Cirrhotic Patients With Ascites [Acute on Chronic Liver Failure] and Acute Deterioration of Previously Decompensated Cirrhosis.
  “Due to lack of funds” (92% match in meaning)
• Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
  “due to financial problems” (85% match in meaning)
• Extended Pelvic Lymph Node Dissection vs. no Pelvic Lymph Node Dissection at Radical Prostatectomy for intermediate-and High-risk Prostate Cancer
  “Due to lack of funding.” (83% match in meaning)
• Effects of Empowerment-based Program on Post-discharge Glycemic Control, and Foot Ulcer
  “Lack of financial resources” (83% match in meaning)
• Safety and Efficacy of Sofosbuvir Based Antiviral Regimen for Treating Hepatitis C in Patients With Moderate to Advanced Chronic Kidney Disease and Patients Receiving Renal Replacement Therapy
  “Lack of funds” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.